Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers
18 Years
N/A
Both
Peritoneal Carcinomatosis
Trial Information
Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers
Inclusion Criteria:
- Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC
- Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian)
peritoneal cancer
- Free consent
- Male or Female
- Age > 18 years
- Affiliate to social security
Exclusion Criteria:
- Age < 18 years, no french speaking
- Cerebrals metastasis
- Psychiatrics diseases
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Outcome Measure:
Body representations
Outcome Description:
Comprehensive knowledge concerning the way the patients are living cancer event, treatment, changes in their body representations and conceptions of their lives. This qualitative study do not include outcome measures. Its purpose is restricted to the meanings
Outcome Time Frame:
3 months
Safety Issue:
No
Principal Investigator
Olivier GLEHEN, Pr
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hospices Civiles de Lyon
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
2010.640
NCT ID:
NCT01560533
Start Date:
November 2011
Completion Date:
January 2013
Related Keywords:
- Peritoneal Carcinomatosis
- Carcinoma
Name | Location |
|---|
